Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/1995
09/21/1995WO1995025120A1 Peptide vaccines and methods relating thereto
09/21/1995WO1995025113A1 Synthetic compounds which bind to h. pylori, and uses thereof
09/21/1995WO1995024927A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
09/21/1995WO1995024926A1 Formulation for use in inducing cytotoxic t-cells
09/21/1995WO1995024925A1 Cytotoxic t-cell epitopes
09/21/1995WO1995024924A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING α-GALACTOSYL EPITOPES
09/21/1995WO1995024923A2 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/21/1995WO1995024922A1 Chlamydia vaccines and process
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024917A1 Skin treatment composition
09/21/1995WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis
09/21/1995WO1995024913A1 Treatment of graft-versus-host disease
09/21/1995WO1995024910A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995WO1995024904A1 Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies
09/21/1995WO1995024896A2 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
09/21/1995WO1995021858A3 Mosaic polypeptide and methods for detecting the hepatitis e virus
09/21/1995WO1995018826A3 Purified primate ctla-8 antigens and related reagents
09/21/1995CA2185675A1 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
09/21/1995CA2185651A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/21/1995CA2185540A1 Formulation for use in inducing cytotoxic t-cells
09/21/1995CA2185539A1 Blood-borne mesenchymal cells
09/21/1995CA2185534A1 Peptide vaccines and methods relating thereto
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2185129A1 Methods to diagnose and treat hiv-1 infection
09/21/1995CA2184352A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995CA2184269A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
09/21/1995CA2181162A1 Skin treatment composition
09/20/1995EP0672685A2 Monoclonal antibody
09/20/1995EP0672421A1 Endothelin activity inhibitor
09/20/1995EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
09/20/1995EP0672157A1 Recombinant viruses comprising artificial proteolytic cleavage site
09/20/1995EP0672156A1 Bovine heat shock promoter and uses thereof
09/20/1995EP0672151A1 Inhibitors of ced-3 and related proteins
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672142A1 Multivalent and multispecific binding proteins, their manufacture and use
09/20/1995EP0672136A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
09/20/1995EP0672134A1 Peptides useful for inducing tolerance
09/20/1995EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
09/20/1995EP0672128A1 Stem cell proliferation factor
09/20/1995EP0672123A1 Multifunctional surface protein of streptococci
09/20/1995EP0672121A1 Papillomavirus: biosynthetic process and assays
09/20/1995EP0672120A1 Production of human monoclonal antibodies active against hepatitis b surface antigen
09/20/1995EP0672116A1 Deletion mutants as vaccines for cholera
09/20/1995EP0672068A1 Target binding polypeptide
09/20/1995EP0672067A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
09/20/1995EP0672066A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
09/20/1995EP0672065A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
09/20/1995EP0672064A1 Op-3-induced morphogenesis
09/20/1995EP0672060A1 Antigen associated with type i diabetes mellitus
09/20/1995EP0672048A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION
09/20/1995EP0671952A1 Method for nonspecific cellular immune stimulation
09/20/1995EP0671951A1 Humanized antibodies reactive with l-selectin
09/20/1995EP0671950A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies
09/20/1995EP0671949A1 USE OF $g(b)-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
09/20/1995EP0671947A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
09/20/1995EP0671946A1 Immunoreactive peptides from epstein-barr virus
09/20/1995EP0671945A1 Methods and compositions for the modulation of host immune response to allergens
09/20/1995EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION
09/20/1995EP0671933A1 Novel uses of il-10
09/20/1995EP0671932A1 Cytokine applications
09/20/1995EP0671928A1 Synthesis of n-substituted oligomers
09/20/1995EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
09/20/1995EP0671926A1 Immunomodulatory peptides
09/20/1995EP0671902A1 $i(CLOSTRIDIAL) TOXIN DISEASE THERAPY
09/20/1995EP0448635B1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
09/20/1995EP0429644B1 Chelating agents for attaching metal ions to proteins
09/20/1995EP0326595B1 Peptides and antibodies that inhibit platelet adhesion
09/20/1995EP0260280B2 Immunoselection method
09/20/1995CN1108695A Expression of e antigen in hay bacillus for hepatitis B virogene engineering
09/20/1995CN1108575A Oil-based and water-based adjuvant mixture
09/19/1995US5451658 Antagonists of human gamma interferon
09/19/1995US5451527 HCG peptides for use in antibody purification procedures
09/19/1995US5451499 Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
09/19/1995US5451412 Biologically active undenatured whey protein concentrate as food supplement
09/19/1995CA1337051C Immunological detection of atrazine and atrazine derivatives
09/19/1995CA1337050C Monoclonal antibody selectively binding to novel g-csf derivative
09/19/1995CA1337047C Gamma inulin compositions
09/14/1995WO1995024490A1 Cell surface protein and effector cell bonding reagent
09/14/1995WO1995024485A2 Coordinate in vivo gene expression
09/14/1995WO1995024481A2 Humanized monoclonal antibodies against human interleukin-4
09/14/1995WO1995024475A1 Vaccine compositions
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024470A1 Activating virus
09/14/1995WO1995024468A1 Hepatitis a virus culture process
09/14/1995WO1995024466A1 Transforming growth factor alpha h1
09/14/1995WO1995024417A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof
09/14/1995WO1995024411A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/14/1995WO1995024220A1 Bispecific molecules having clinical utilities
09/14/1995WO1995024217A1 Methods for modulating t cell unresponsiveness
09/14/1995WO1995024216A1 Prevention of diabetes
09/14/1995WO1995024215A1 Retroviral vaccines, vaccination and immune-therapy for retroviral infections
09/14/1995WO1995024214A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
09/14/1995WO1995024198A1 DIROFILARIA IMMITIS Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF
09/14/1995WO1995024182A1 Human osteoclast-derived cathepsin
09/14/1995DE4407545A1 Use of a modified saccharide, esp. derived from bacterium or parasite
09/14/1995DE4407489A1 Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines Vaccine for the prevention of respiratory and reproductive diseases of the pig
09/14/1995CA2443236A1 Human osteoclast-derived cathepsin
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2185097A1 Activating virus
1 ... 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 ... 1823